Effectiveness and safety of rituximab in Takayasu arteritis: a multicenter retrospective study

Arsène Mekinian1, Lucie Noé2, Carlo Salvarani3

  • 1Service de médecine interne et Inflammation-Immunopathology-Biotherapy Department (DMU i3), Sorbonne Université, AP-HP, Hôpital Saint Antoine, 75012 Paris, France; French Armenian research center, Erevan, Armenia.

Joint Bone Spine
|November 1, 2023
PubMed
Abstract

No abstract available in PubMed .